4186.Two

4186.TWO has a debt-to-equity ratio of 0.87, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company holds cash and equivalents of TWD 140.7 million, but its long-term debt of TWD 248.6 million exceeds its cash reserves, resulting in a net cash position that is negative after subtracting total debt. This suggests potential liquidity constraints, especially if the company needs to refinance or service its debt obligations in the near term.

In terms of profitability, the company's operating cash flow of TWD 53.1 million indicates positive cash generation from operations, which is a positive sign for its ability to fund ongoing operations and potentially reduce debt. However, the company's profitability metrics, such as return on invested capital (ROIC) and operating margins, are not provided in the available data, making it difficult to assess its efficiency and profitability relative to industry benchmarks.

The company's revenue of TWD 364.8 million is derived from its healthcare diagnostics business, but the data does not provide a breakdown of revenue by geographic region or business segment. This lack of detail limits the ability to assess the company's exposure to different markets or the performance of its various product lines.

Looking at the company's growth trajectory, the available data does not include specific revenue growth rates or future projections. Without this information, it is challenging to determine whether the company is experiencing growth or facing headwinds in its core markets. The absence of detailed outlook data also makes it difficult to assess the company's strategic direction and potential for future expansion.

The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The liquidity risk is primarily due to the negative net cash position after accounting for long-term debt, which could pose challenges if the company needs to access additional financing. The low dilution risk suggests that the company is not currently issuing a significant number of new shares, which helps maintain shareholder value.

Recent events and filings have not been disclosed in the available data, so there is no information on recent corporate actions, earnings reports, or management commentary that could provide further insight into the company's performance or strategic initiatives.